Strategies for Delivering Anti-HIV Therapy in South Africa

NACompletedINTERVENTIONAL

Enrollment

813

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

January 31, 2007

Conditions

HIV Infections

Interventions

BEHAVIORAL

Monitoring by HIV-trained primary care nurses

BEHAVIORAL

Community-based directly observed therapy (DOT)

DRUG

stavudine

DRUG

lamivudine

DRUG

efavirenz

DRUG

zidovudine

DRUG

didanosine

DRUG

lopinavir/ritonavir

Trial Locations (2)

University of the Witwatersrand/Clinical HIV Research Unit, Johannesburg

University of Cape Town/Masiphumelele, Cape Town

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00080522 - Strategies for Delivering Anti-HIV Therapy in South Africa | Biotech Hunter | Biotech Hunter